These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6320358)

  • 1. Toxic hepatitis following ketoconazole treatment.
    Svedhem A
    Scand J Infect Dis; 1984; 16(1):123-5. PubMed ID: 6320358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole-induced fulminant hepatitis necessitating liver transplantation.
    Knight TE; Shikuma CY; Knight J
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):398-400. PubMed ID: 1832694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ketoconazole-induced hepatitis. Case report].
    Henning H; Kasper B; Lüders CJ
    Z Gastroenterol; 1983 Dec; 21(12):709-15. PubMed ID: 6141674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute hepatocytic necrosis during ketoconazole therapy for treatment of onychomycosis. National Foundation for Registry and Evaluation of Adverse Effects].
    Van Puijenbroek EP; Metselaar HJ; Berghuis PH; Zondervan PE; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2416-8. PubMed ID: 9864540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis.
    Brusko CS; Marten JT
    DICP; 1991 Dec; 25(12):1321-5. PubMed ID: 1815425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketoconazole and hepatitis.
    Klausner MA
    J Am Acad Dermatol; 1992 Jun; 26(6):1028-30. PubMed ID: 1535078
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal hepatitis associated with ketoconazole therapy.
    Duarte PA; Chow CC; Simmons F; Ruskin J
    Arch Intern Med; 1984 May; 144(5):1069-70. PubMed ID: 6324708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis.
    Tkach JR; Rinaldi MG
    Cutis; 1982 May; 29(5):482-4. PubMed ID: 6284445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxic hepatitis caused by ketoconazole: a report of 4 cases].
    Vilela MP; Ferraz ML; Franco DR
    Rev Paul Med; 1989; 107(1):57-8. PubMed ID: 2616978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketoconazole treatment of chronic mucocutaneous candidiasis.
    Montagnani A; Negosanti M; Patrizi A
    Drugs Exp Clin Res; 1986; 12(5):409-12. PubMed ID: 3522160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of benefit against risk of ketoconazole therapy.
    Seebacher C
    Ther Hung; 1986; 34(4):227-32. PubMed ID: 2966995
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketoconazole and the antifungals.
    Parkin JL
    Otolaryngol Head Neck Surg; 1985 Feb; 93(1):132-3. PubMed ID: 3920612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic injury during ketoconazole therapy in patients with onychomycosis: a controlled cohort study.
    Chien RN; Yang LJ; Lin PY; Liaw YF
    Hepatology; 1997 Jan; 25(1):103-7. PubMed ID: 8985273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial.
    Mobacken H; Moberg S
    Dermatologica; 1986; 173(5):229-36. PubMed ID: 3100354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ketoconazole and onychomycosis].
    Parent D; Achten G; André J; Wiame L
    Ann Dermatol Venereol; 1984; 111(4):339-44. PubMed ID: 6089641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
    Horsburgh CR; Kirkpatrick CH
    Am J Med; 1983 Jan; 74(1B):23-9. PubMed ID: 6295149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole.
    Deutsch PH; Quintiliani R
    Conn Med; 1984 Apr; 48(4):216-21. PubMed ID: 6325087
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketoconazole: an orally effective antifungal agent. Mechanism of action, pharmacology, clinical efficacy and adverse effects.
    Smith EB; Henry JC
    Pharmacotherapy; 1984; 4(4):199-204. PubMed ID: 6091064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoconazole-induced hepatitis: a case with a definite cause-effect relationship.
    van Parys G; Evenepoel C; van Damme B; Desmet VJ
    Liver; 1987 Feb; 7(1):27-30. PubMed ID: 2952860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rise and Fall of Oral Ketoconazole.
    Gupta AK; Lyons DC
    J Cutan Med Surg; 2015; 19(4):352-7. PubMed ID: 25775613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.